Published in J Virol on July 01, 1987
A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells. J Virol (1988) 7.80
Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J Virol (1988) 4.32
A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J Virol (1992) 4.12
Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells. J Virol (1990) 3.35
Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors. J Virol (1988) 3.33
Isolation and characterization of a hepatitis B virus endemic in herons. J Virol (1988) 3.23
Specific pseudorabies virus infection of the rat visual system requires both gI and gp63 glycoproteins. J Virol (1993) 2.92
Inhibition of virion maturation by simultaneous deletion of glycoproteins E, I, and M of pseudorabies virus. J Virol (1999) 2.52
Isolation of a herpes simplex virus type 1 mutant with a deletion in the virion host shutoff gene and identification of multiple forms of the vhs (UL41) polypeptide. J Virol (1993) 2.45
Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking. J Virol (1997) 2.34
Complex between glycoproteins gI and gp63 of pseudorabies virus: its effect on virus replication. J Virol (1988) 2.24
Identification and characterization of a novel herpes simplex virus glycoprotein, gK, involved in cell fusion. J Virol (1992) 2.21
Herpes simplex virus gE/gI sorts nascent virions to epithelial cell junctions, promoting virus spread. J Virol (2001) 2.18
Role of the cytoplasmic tail of pseudorabies virus glycoprotein E in virion formation. J Virol (2000) 2.17
The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions. J Virol (1998) 2.14
A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J Virol (1989) 2.08
Role of pseudorabies virus Us9, a type II membrane protein, in infection of tissue culture cells and the rat nervous system. J Virol (2000) 1.97
Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol (2002) 1.92
Cytoplasmic domain of herpes simplex virus gE causes accumulation in the trans-Golgi network, a site of virus envelopment and sorting of virions to cell junctions. J Virol (2001) 1.91
Intracellular traffic of herpes simplex virus glycoprotein gE: characterization of the sorting signals required for its trans-Golgi network localization. J Virol (1999) 1.87
Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J Virol (1992) 1.81
Glycoproteins M and N of pseudorabies virus form a disulfide-linked complex. J Virol (1998) 1.79
Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1. J Virol (1990) 1.73
Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J Virol (1991) 1.73
The extracellular domain of herpes simplex virus gE is sufficient for accumulation at cell junctions but not for cell-to-cell spread. J Virol (2000) 1.65
Herpes simplex virus glycoproteins gD and gE/gI serve essential but redundant functions during acquisition of the virion envelope in the cytoplasm. J Virol (2003) 1.63
Antigenic properties and cellular localization of herpes simplex virus glycoprotein H synthesized in a mammalian cell expression system. J Virol (1989) 1.59
In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J Virol (1998) 1.59
Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system. J Virol (1993) 1.58
Complementation analysis of pseudorabies virus gE and gI mutants in retinal ganglion cell neurotropism. J Virol (1994) 1.52
Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J Virol (1997) 1.50
Cytoplasmic residues of herpes simplex virus glycoprotein gE required for secondary envelopment and binding of tegument proteins VP22 and UL11 to gE and gD. J Virol (2006) 1.46
Deletions in herpes simplex virus glycoprotein D define nonessential and essential domains. J Virol (1990) 1.44
Herpes simplex virus gE/gI must accumulate in the trans-Golgi network at early times and then redistribute to cell junctions to promote cell-cell spread. J Virol (2006) 1.39
Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes. J Virol (1990) 1.38
Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates. J Virol (1994) 1.36
Efficient axonal localization of alphaherpesvirus structural proteins in cultured sympathetic neurons requires viral glycoprotein E. J Virol (2005) 1.36
Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. J Virol (1996) 1.36
Herpes simplex virus gE/gI and US9 proteins promote transport of both capsids and virion glycoproteins in neuronal axons. J Virol (2008) 1.36
Herpes simplex virus glycoprotein K is known to influence fusion of infected cells, yet is not on the cell surface. J Virol (1995) 1.34
Role of the pseudorabies virus gI cytoplasmic domain in neuroinvasion, virulence, and posttranslational N-linked glycosylation. J Virol (2000) 1.31
Herpes simplex virus type 1 glycoprotein e is required for axonal localization of capsid, tegument, and membrane glycoproteins. J Virol (2005) 1.29
Pseudorabies virus recombinants expressing functional virulence determinants gE and gI from bovine herpesvirus 1.1. J Virol (1997) 1.27
Localization on the herpes simplex virus type 1 genome of a region encoding proteins involved in adsorption to the cellular receptor. J Virol (1990) 1.26
Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J Virol (1994) 1.24
Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J Virol (1994) 1.23
Structural basis of C3b binding by glycoprotein C of herpes simplex virus. J Virol (1992) 1.23
Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease. J Virol (2000) 1.19
Disulfide bond structure determination and biochemical analysis of glycoprotein C from herpes simplex virus. J Virol (1996) 1.19
Herpes simplex virus gE/gI expressed in epithelial cells interferes with cell-to-cell spread. J Virol (2003) 1.17
Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody. J Virol (2006) 1.17
Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J Virol (2001) 1.15
Expression of bovine herpesvirus 1 glycoproteins gI and gIII in transfected murine cells. J Virol (1988) 1.14
C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2. J Virol (1988) 1.14
Synthesis, processing, and oligomerization of bovine herpesvirus 1 gE and gI membrane proteins. J Virol (1996) 1.10
Glycoproteins E and I of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J Virol (2001) 1.06
Bovine herpesvirus 5 glycoprotein E is important for neuroinvasiveness and neurovirulence in the olfactory pathway of the rabbit. J Virol (2000) 1.04
Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein C. J Virol (1990) 1.02
Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus. J Virol (2006) 1.01
Biosynthesis of glycoproteins E and I of feline herpesvirus: gE-gI interaction is required for intracellular transport. J Virol (1996) 1.00
Antibody evasion by the N terminus of murid herpesvirus-4 glycoprotein B. EMBO J (2007) 1.00
Structure-function analysis of the gE-gI complex of feline herpesvirus: mapping of gI domains required for gE-gI interaction, intracellular transport, and cell-to-cell spread. J Virol (1997) 0.99
Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor. J Virol (2004) 0.98
Post-exposure vaccination improves gammaherpesvirus neutralization. PLoS One (2007) 0.96
Sequence and genetic arrangement of the U(S) region of the monkey B virus (cercopithecine herpesvirus 1) genome and comparison with the U(S) regions of other primate herpesviruses. J Virol (2002) 0.96
Complement and its role in protection and pathogenesis of flavivirus infections. Vaccine (2008) 0.96
Herpes simplex virus 1 pUL34 plays a critical role in cell-to-cell spread of virus in addition to its role in virus replication. J Virol (2011) 0.93
Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells. Immunology (1992) 0.93
The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo. J Virol (2011) 0.93
Recognition of similar epitopes on varicella-zoster virus gpI and gpIV by monoclonal antibodies. J Virol (1988) 0.91
Expression of herpes simplex virus type 1 glycoprotein I in baculovirus: preliminary biochemical characterization and protection studies. J Virol (1992) 0.90
Replication of herpes simplex virus: egress of progeny virus at specialized cell membrane sites. J Virol (2012) 0.86
The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surface. PLoS Pathog (2014) 0.85
Herpes simplex type 1-induced Fc receptor binds to the Cgamma2-Cgamma3 interface region of IgG in the area that binds staphylococcal protein A. Immunology (1989) 0.85
Expression and characterization of duck enteritis virus gI gene. Virol J (2011) 0.84
Responses of herpes simplex virus type 1-infected cells to the presence of extracellular antibodies: gE-dependent glycoprotein capping and enhancement in cell-to-cell spread. J Virol (2003) 0.83
The herpes simplex virus 1 UL51 protein interacts with the UL7 protein and plays a role in its recruitment into the virion. J Virol (2014) 0.82
An indirect double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) using baculovirus-expressed antigen for the detection of antibodies to glycoprotein E of pseudorabies virus and comparison of the method with blocking ELISAs. Clin Diagn Lab Immunol (1996) 0.81
Studies of protein A and herpes simplex virus-1 induced Fc gamma-binding specificities. Different binding patterns for IgG3 from Caucasian and Oriental subjects. Immunology (1994) 0.77
The disulfide-bonded structure of feline herpesvirus glycoprotein I. J Virol (1998) 0.76
Genital Herpes: Insights into Sexually Transmitted Infectious Disease. Microb Cell (2016) 0.75
The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects. PLoS One (2017) 0.75
Complement Evasion Strategies of Viruses: An Overview. Front Microbiol (2017) 0.75
A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22
Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem (1977) 72.51
Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains. J Virol (1974) 16.33
An Hsp70-like protein in the ER: identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein. Cell (1986) 10.38
Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas. J Cell Biol (1986) 8.65
Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J Mol Biol (1985) 7.32
Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J Virol (1979) 5.52
Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells. J Virol (1982) 4.74
Herpes simplex virus type-1 glycoprotein D gene: nucleotide sequence and expression in Escherichia coli. Science (1982) 4.28
O-linked oligosaccharides are acquired by herpes simplex virus glycoproteins in the Golgi apparatus. Cell (1983) 3.73
Enzymatic iodination of Sindbis virus proteins. J Virol (1973) 3.36
The IgG receptor induced by herpes simplex virus: studies using radioiodinated IgG. J Gen Virol (1974) 3.17
Immunoglobulin G(Fc)-binding receptors on virions of herpes simplex virus type 1 and transfer of these receptors to the cell surface by infection. J Virol (1980) 3.16
An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts. J Immunol (1976) 3.14
Location of the structural genes for glycoproteins gD and gE and for other polypeptides in the S component of herpes simplex virus type 1 DNA. J Virol (1982) 2.85
ADSORPTION OF SENSITIZED SHEEP ERYTHROCYTES TO HELA CELLS INFECTED WITH HERPES SIMPLEX VIRUS. Nature (1964) 2.78
Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus-induced fc-binding receptors. J Virol (1982) 2.68
Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart. Virology (1984) 2.56
Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein. J Virol (1982) 2.55
Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions. J Virol (1985) 2.42
Cells that constitutively express the herpes simplex virus immediate-early protein ICP4 allow efficient activation of viral delayed-early genes in trans. J Virol (1985) 2.40
Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J Virol (1984) 2.36
Identification, properties, and gene location of a novel glycoprotein specified by herpes simplex virus 1. Virology (1986) 2.29
Endo-beta-N-acetylglucosaminidase H sensitivity of precursors to herpes simplex virus type 1 glycoproteins gB and gC. J Virol (1982) 2.13
The development by cytomegalovirus-infected cells of binding affinity for normal human immunoglobulin. J Immunol (1976) 2.12
Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it. J Virol (1986) 2.07
Appearance of IgG (Fc) receptor(s) on cultured human fibroblasts infected with human cytomegalovirus. J Immunol (1976) 2.05
Possible role of Fc receptors on cells infected and transformed by herpesvirus: escape from immune cytolysis. Infect Immun (1978) 1.93
Fc receptors induced by herpes simplex virus. I. Biologic and biochemical properties. J Immunol (1978) 1.85
The heavy chain of human histocompatibility antigen HLA-B7 contains an immunoglobulin-like region. Nature (1979) 1.70
Herpes simplex virus infection causes the accumulation of a heat-shock protein. EMBO J (1984) 1.67
Herpes simplex virus glycoprotein gA/B: evidence that the infected Vero cell products comap and arise by proteolysis. J Virol (1982) 1.62
Evolutionary comparisons of the S segments in the genomes of herpes simplex virus type 1 and varicella-zoster virus. J Gen Virol (1986) 1.59
Immunological basis for latency, recurrences and putative oncogenicity of herpes simplex virus. Lancet (1975) 1.55
Studies on benzhydrazone, a specific inhibitor of herpesvirus glycoprotein synthesis. Size distribution of glycopeptides and endo-beta-N-acetylglucosaminidase-H treatment. Arch Virol (1981) 1.55
Hemadsorption by herpes simplex-infected cell cultures. Int Arch Allergy Appl Immunol (1968) 1.48
Detection by indirect immunofluorescence of Fc receptors in cells acutely infected with Herpes simplex virus. Int Arch Allergy Appl Immunol (1977) 1.46
Sulphated glycoproteins induced by herpes simplex virus. J Gen Virol (1982) 1.40
Appearance of immunoglobulin G Fc receptor in cultured human cells infected with varicella-zoster virus. Infect Immun (1979) 1.38
Limited proteolysis of herpes simplex virus glycoproteins that occurs during their extraction from vero cells. J Virol (1984) 1.27
Properties of the cell surface Fc-receptor induced by herpes simplex virus. J Immunol (1978) 1.26
Role of Fc receptors in herpes simplex virus infection. Lancet (1975) 1.11
Novel herpes simplex virus type 1 glycoproteins identified by antiserum against a synthetic oligopeptide from the predicted product of gene US4. J Gen Virol (1986) 1.05
Standardisation of spirometry. Eur Respir J (2005) 48.20
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
General considerations for lung function testing. Eur Respir J (2005) 7.99
A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells. J Virol (1988) 7.80
Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J (2005) 7.58
Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells. J Virol (1982) 4.74
A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell (1994) 4.70
A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J Virol (1993) 4.67
A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J Virol (1992) 4.12
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J Virol (1987) 3.74
O-linked oligosaccharides are acquired by herpes simplex virus glycoproteins in the Golgi apparatus. Cell (1983) 3.73
Environmental tobacco smoke and cardiovascular disease. A position paper from the Council on Cardiopulmonary and Critical Care, American Heart Association. Circulation (1992) 3.47
Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J Virol (1994) 3.39
Vesicular stomatitis virus and sindbis virus glycoprotein transport to the cell surface is inhibited by ionophores. Virology (1980) 3.13
Type-A influenza viruses isolated from wild free-flying ducks in California. Avian Dis (1974) 2.98
Noninvasive ventilation. N Engl J Med (1997) 2.82
Implementation and evaluation of an algorithm for isolation of patients with suspected pulmonary tuberculosis. Infect Control Hosp Epidemiol (1996) 2.62
Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res (1993) 2.61
Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J Virol (1995) 2.52
Scanning fluorescence correlation spectroscopy. II. Application to virus glycoprotein aggregation. Biophys J (1986) 2.33
Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J (1996) 2.26
Identification and characterization of a novel herpes simplex virus glycoprotein, gK, involved in cell fusion. J Virol (1992) 2.21
Binding to cells of virosomes containing herpes simplex virus type 1 glycoproteins and evidence for fusion. J Virol (1984) 2.21
The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions. J Virol (1998) 2.14
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med (1999) 2.08
Herpes simplex virus glycoprotein K promotes egress of virus particles. J Virol (1995) 2.04
Identification and characterization of the virion-induced host shutoff product of herpes simplex virus gene UL41. J Gen Virol (1992) 1.92
Cytoplasmic domain of herpes simplex virus gE causes accumulation in the trans-Golgi network, a site of virus envelopment and sorting of virions to cell junctions. J Virol (2001) 1.91
Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. J Immunol (1996) 1.88
Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response. J Exp Med (1998) 1.85
The extracellular domain of herpes simplex virus gE is sufficient for accumulation at cell junctions but not for cell-to-cell spread. J Virol (2000) 1.65
Does the presence of ant nests matter for oviposition to a specialized myrmecophilous Maculinea butterfly? Proc Biol Sci (2000) 1.62
Role of mannose-6-phosphate receptors in herpes simplex virus entry into cells and cell-to-cell transmission. J Virol (1995) 1.58
Herpes simplex virus glycoprotein D acquires mannose 6-phosphate residues and binds to mannose 6-phosphate receptors. J Biol Chem (1994) 1.57
Intracellular transport of herpes simplex virus gD occurs more rapidly in uninfected cells than in infected cells. J Virol (1985) 1.56
The ICP4 binding sites in the herpes simplex virus type 1 glycoprotein D (gD) promoter are not essential for efficient gD transcription during virus infection. J Virol (1992) 1.51
Antigenic and functional analysis of a neutralization site of HSV-1 glycoprotein D. Virology (1990) 1.49
Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes. J Virol (1987) 1.48
Herpes simplex virus IgG Fc receptors induced using recombinant adenovirus vectors expressing glycoproteins E and I. Virology (1990) 1.45
Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocyte clones. Virology (1993) 1.44
Efficacy of iodine water purification tablets against Cryptosporidium oocysts and Giardia cysts. Wilderness Environ Med (1997) 1.44
Deletions in herpes simplex virus glycoprotein D define nonessential and essential domains. J Virol (1990) 1.44
Surgical therapy for atrial tachycardia in adults. J Am Coll Cardiol (1989) 1.41
Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J Infect Dis (1993) 1.37
Fluorescence photobleaching recovery measurements reveal differences in envelopment of Sindbis and vesicular stomatitis viruses. Cell (1981) 1.36
Herpes simplex virus glycoprotein K is known to influence fusion of infected cells, yet is not on the cell surface. J Virol (1995) 1.34
Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J Virol (1998) 1.33
Evidence for translational regulation of herpes simplex virus type 1 gD expression. J Virol (1984) 1.24
Herpes simplex virus with highly reduced gD levels can efficiently enter and spread between human keratinocytes. J Virol (2001) 1.21
Complications following closure of atrial septal defects of the inferior vena caval type. Thorax (1972) 1.21
Herpes simplex virus gD and virions accumulate in endosomes by mannose 6-phosphate-dependent and -independent mechanisms. J Virol (1998) 1.18
Herpes simplex virus (HSV) glycoproteins B and K inhibit cell fusion induced by HSV syncytial mutants. Virology (1993) 1.18
Differential spatiotemporal regulation of lactoferrin and progesterone receptor genes in the mouse uterus by primary estrogen, catechol estrogen, and xenoestrogen. Endocrinology (1998) 1.17
Effectiveness of screening aqueous contrast swallow in detecting clinically significant anastomotic leaks after esophagectomy. Eur Surg Res (2005) 1.14
Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47. J Virol (1998) 1.14
Pathogenicity in mice of herpes simplex virus type 2 mutants unable to express glycoprotein C. J Virol (1986) 1.14
Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B. Virology (1989) 1.12
Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteins. J Gen Virol (1990) 1.11
Hydrazine sulfate protects D-galactosamine-sensitized mice against endotoxin and tumor necrosis factor/cachectin lethality: evidence of a role for the pituitary. J Exp Med (1991) 1.09
Curative surgery for atrioventricular junctional ("AV nodal") reentrant tachycardia. J Am Coll Cardiol (1985) 1.07
Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am J Respir Crit Care Med (1996) 1.04
High resolution mapping of Koch's triangle using sixty electrodes in humans with atrioventricular junctional (AV nodal) reentrant tachycardia. Circulation (1993) 1.03
Medial prefrontal cortex activity can disrupt the expression of stress response habituation. Neuroscience (2010) 1.02
Gluconeogenesis in rabbit liver. I. Pyruvate-derived dicarboxylic acids and phosphoenolpyruvate formation in rabbit liver. J Biol Chem (1973) 1.02
Profound hypothermia with circulatory arrest: nine years' clinical experience. J Thorac Cardiovasc Surg (1982) 1.02
Definition of COPD: based on evidence or opinion? Eur Respir J (2008) 1.01
Preoperative predictors of operative morbidity and mortality in COPD patients undergoing bilateral lung volume reduction surgery. Chest (1997) 1.00
Comparison of the sensitivity of the caudal fold skin test and a commercial gamma-interferon assay for diagnosis of bovine tuberculosis. Am J Vet Res (1995) 0.96
Bragg gratings in defect-free germanium-doped optical fibers. Opt Lett (1999) 0.96
Wheezing on maximal forced exhalation in the diagnosis of atypical asthma. Lack of sensitivity and specificity. Ann Intern Med (1989) 0.96
2-methoxyestradiol-induced growth suppression and lethality in estrogen-responsive MCF-7 cells may be mediated by down regulation of p34cdc2 and cyclin B1 expression. Int J Oncol (1999) 0.95
Effects of passive smoking on the pulmonary function of adults. Thorax (1990) 0.94
Reproductive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in female rats: ovulation, hormonal regulation, and possible mechanism(s). Toxicol Appl Pharmacol (1995) 0.93
Aorta-coronary bypass grafting with polytetrafluoroethylene conduits. Early and late outcome in eight patients. J Thorac Cardiovasc Surg (1987) 0.93
Narrow-band Bragg reflectors in optical fibers. Opt Lett (1978) 0.92
Angiographic assessment of anomalous origin of the left coronary from the pulmonary artery in infancy and childhood. Pediatr Radiol (1976) 0.91
Incidence of tenosynovitis in Maine broilers. Avian Dis (1972) 0.90
Pharmacology of the bipyridines: amrinone and milrinone. Circulation (1986) 0.90
Acute lymphocytic leukemia developing in a male with germ cell carcinoma: a case report. Med Pediatr Oncol (1980) 0.90
Regulation of cerebrospinal fluid acid-base balance. Physiol Rev (1986) 0.89
Immunogenicity in mice of tandem repeats of an epitope from herpes simplex gD protein when expressed by recombinant adenovirus vectors. Vaccine (1993) 0.89
An occurrence of avian influenza virus infection in laying chickens. Avian Dis (1976) 0.88
Serum estrogens and gonadotropins in developing androgenized and normal female rats. Neuroendocrinology (1974) 0.87
The renin-like enzyme of rabbit uterus. Biochim Biophys Acta (1969) 0.86
Epidemiologic studies of the 1975 avian influenza outbreak in chickens in Alabama. Avian Dis (1977) 0.86
Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on estrous cyclicity and ovulation in female Sprague-Dawley rats. Toxicol Lett (1995) 0.86
Endogenous and exogenous glucocorticoids have different roles in modulating endotoxin lethality in D-galactosamine-sensitized mice. Infect Immun (1993) 0.86
Direct contact with herpes simplex virus-infected cells results in inhibition of lymphokine-activated killer cells because of cell-to-cell spread of virus. J Infect Dis (1993) 0.86
The closed heart MAZE: a nonbypass surgical technique. Ann Thorac Surg (1999) 0.85
MMSET is the key molecular target in t(4;14) myeloma. Blood Cancer J (2013) 0.85
Intracardiac repair of large ventricular septal defect in the first year of life. Med J Aust (1974) 0.85
Determination of nitrate and nitrite by forced-flow liquid chromatography with electrochemical detection. Anal Chem (1974) 0.85
Serum and pituitary prolactin, LH, and FSH in androgenized female and normal male rats treated with various doses of estradiol benzoate. Neuroendocrinology (1973) 0.85
Diagnosis, pathology, and etiology of tenosynovitis in broilers and broiler breeders. Avian Dis (1973) 0.85
Cytochrome P450 17 alpha-hydroxylase gene expression in differentiating rat trophoblast cells. J Endocrinol (1996) 0.84
Compact, low-loss, fused biconical taper couplers: overcoupled operation and antisymmetric supermode cutoff. Opt Lett (1987) 0.84
Oesophageal cancer: outcome of modern surgical management. Aust N Z J Surg (1995) 0.84
The recurrent and external laryngeal nerves in thyroidectomy. Med J Aust (1969) 0.84
Dimensions of the triangle of Koch in humans. Am J Cardiol (1992) 0.83